MedTrace Logo

Radioisotope and Fluorescence Guidance in Rectal Cancer

NCT05336643 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-11-01

No results posted yet for this study

Summary

A study to investigate if pelvic side wall lymph nodes that remain after neo-adjuvant chemoradiotherapy can be identified intraoperatively using dual radioisotope and fluorescence guidance.

Conditions

Interventions

DEVICE

Radiofluorescence

Assessment of pelvic sidewall with Firefly and Sensei

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Simon Wan · University College London Hospitals

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2023-01-31
Completion
2024-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05336643 on ClinicalTrials.gov